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Various specialized domains have been described in
the cytosol and the nucleus; however, little is known
about compartmentalizationwithin themitochondrial
matrix. GRSF1 (G-rich sequence factor 1) is an RNA
binding protein that was previously reported to
localize in the cytosol. We found that an isoform of
GRSF1 accumulates in discrete foci in the mitochon-
drial matrix. These foci are composed of nascent
mitochondrial RNA and also contain RNase P, an
enzyme that participates in mitochondrial RNA pro-
cessing. GRSF1 was found to interact with RNase P
and to be required for processing of both classical
and tRNA-less RNA precursors. In its absence,
cleavage of primary RNA transcripts is abnormal,
leading to decreased expression of mitochondrially
encoded proteins and mitochondrial dysfunction.
Our findings suggest that the foci containing
GRSF1 and RNase P correspond to sites where
primary RNA transcripts converge to be processed.
We have termed these large ribonucleoprotein struc-
tures ‘‘mitochondrial RNA granules.’’
INTRODUCTION
Mitochondria are involved in many metabolic processes, a pri-
mary function being to convert energy from nutrients into ATP
through oxidative phosphorylation. These organelles are thought
to derive from an ancient endosymbiotic event between an
a-proteobacterium and the ancestor of modern eukaryotic cells.
Over evolutionary time most of the ancestral bacterial genes
have been transferred to the nucleus, requiring >1,000 nuclear-
encoded proteins to translocate to the mitochondrion following
cytosolic synthesis (Pagliarini et al., 2008). As a result, mostmito-
chondrial genomes are generally smaller than their bacterial
ancestors, as is the case for the 16.6 kb human mitochondrial
DNA (mtDNA).
The human mitochondrial genome encodes two ribosomal
RNAs, 22 tRNAs, and 13 open reading frames (ORFs) that are
transcribed and translated within the organelle. The mitochon-Cedrial genetic information is indispensable for the function of
respiratory complexes I, III, IV, and V, as exemplified by the large
number of human disorders attributed to mtDNA mutations and
the role such mutations may play in aging (Trifunovic et al., 2004;
Wallace, 1997).
Mitochondrial transcription occurs on both DNA strands and
gives rise to three polycistronic primary transcripts (Montoya
et al., 1983). The primary mitochondrial transcripts are com-
posed of ORFs and rRNAs that are usually punctuated by tRNAs
(Ojala et al., 1981). Cleavage of tRNAs at their 50 and 30 ends
by RNase P and RNase Z, respectively, releases individual
RNA species from the polycistronic precursor that are further
matured, as reviewed by Temperley et al. (2010). Defects inmito-
chondrial RNA (mtRNA) processing have been associated with
several mitochondrial disorders (Suzuki et al., 2011), making it
important to understand in more detail how mtRNA processing
is spatially and temporally organized with regard to both tran-
scription and translation.
Recently, one of the RNA processing enzymes was identified
in mitochondria (Holzmann et al., 2008). It is a protein-only
RNase P, composed of three subunits, MRPP1 (RG9MTD1),
MRPP2 (HSD17B1), and MRPP3 (KIAA0391). These three pro-
teins are necessary and sufficient for 50 tRNA processing
in vitro. An additional RNA-containing RNase P has been re-
ported, but its substrate specificity has not been confirmed
(Chen et al., 2006). Processing of the tRNA 30 end is performed
by an RNase Z type enzyme, namely ELAC2 (Brzezniak et al.,
2011; Sanchez et al., 2011). Four of the mtORFs are not flanked
on both sides by a tRNA. The 50 junction ofMTCO1with noncod-
ing RNA (ncRNA) does not have an intervening canonical tRNA.
However, the upstream ncRNA sequence has been proposed to
adopt a tRNA-like structure, and so the processing of this tran-
scription unit also depends onRNase P (Mercer et al., 2011; San-
chez et al., 2011). The three other ORF junctions that are devoid
of tRNAs are MTND6-ncRNA, MTND5-MTCYB, and RNA14-
MTCO3, and these do not depend on RNase P/Z for their pro-
cessing (Brzezniak et al., 2011; Sanchez et al., 2011). In the
case ofMTND5-MTCYB, it has been shown that the pentatrico-
peptide-containing protein PTCD2 is necessary for processing
(Xu et al., 2008), but, to our knowledge, no factor has been iden-
tified that can resolve the processing of the two others.
GRSF1 (G-rich sequence factor 1) was originally identified
as a cytosolic RNA-binding protein with high affinity for G-rich
sequences (Qian andWilusz, 1994). GRSF1 belongs to the familyll Metabolism 17, 399–410, March 5, 2013 ª2013 Elsevier Inc. 399
Figure 1. GRSF1 Is a Mitochondrial Protein
(A) Schematic representation of GRSF1 isoform 1
and 2. MTS, mitochondrial targeting signal pre-
dicted by the MitoProt algorithm (http://ihg.gsf.de/
ihg/mitoprot.html). qRRM, quasi-RNA-recognition
motif. RNAi, targeting sites of GRSF1 RNAi1 and
RNAi2. MitoProt, probability of mitochondrial
import according to MitoProt algorithm.
(B) Confocal analysis of GRSF1 isoforms. HeLa
cells were transfected with GRSF1-isoform1-
mCherry (top panel) or GRSF1-isoform2-mCherry
(middle panel) and immunolabeled with anti-
Tom20. Bottom panel, endogenous GRSF1 and
Tom20 were immunolabeled in 143B cells.
Arrowheads, foci formed by GRSF1 in mito-
chondria.
(C) Import of radiolabeled in vitro-translated
GRSF1 isoforms into isolated 143B mitochondria.
p, precursor. m, mature. DJm, mitochondrial
membrane potential. PK, Proteinase K. Note
that precursor GRSF1 migrates at 70 kDa
instead of the predicted 53 kDa, and mature
GRSF1 runs at 55 kDa instead of the predicted
43 kDa.
(D) Immunoblot analysis of mitochondrial extract
after Proteinase K accessibility test. PK, Pro-
teinase K. TX-100, Triton X-100. OPA1 is
a mitochondrial intermembrane space protein
anchored to the inner membrane; Tom20 is
a mitochondrial outer-membrane protein; mtSSB
is a mitochondrial matrix protein. Note that
mature endogenous GRSF1 migrates at ca
55kDa, similar to in vitro-translated GRSF1 after
import (C).
(E) Immunoblot analysis of mitochondrial extract
after alkaline sodium carbonate (Na2CO3) extrac-
tion. T, total extract. S, supernatant. P, pellet. PHB,
prohibitin 1. Cyt c, cytochrome c.
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Role of GRSF1 in Mitochondrial RNA Granulesof heterogeneous nuclear ribonucleoproteins F/H (hnRNP)
(Schaub et al., 2007) and contains three quasi-RNA-recognition
motifs (qRRM) (Ufer, 2012). Members of this family are involved
in different steps of posttranscriptional RNA processing, such as
RNA splicing, polyadenylation, and transport in RNA granules, as
shown in oligodendrocytes (Han et al., 2010; White et al., 2012).
Moreover, GRSF1 has been reported to play a role in the trans-
lation of mRNA species of both cellular and viral origin, including
those containing IRES elements (Jablonski and Caputi, 2009;
Kash et al., 2002; Park et al., 1999; Ufer et al., 2008). Thus,
GRSF1 appears to be a multifunctional protein, whose function
is likely to involve binding to G-rich sequences (Ufer, 2012).
Recently, GRSF1 has been identified in a proteomic analysis of
mitochondria and appeared in a list of proteins required for
oxidative phosphorylation (Bayona-Bafaluy et al., 2011; R.N.L.,
unpublished data; Pagliarini et al., 2008). The mitochondrial
function of GRSF1 remains to be elucidated.
Here, we report that an isoform of GRSF1 resides in a novel
mitochondrial structure that we have called ‘‘mitochondrial
RNA granules,’’ where it plays an essential role in precursor
RNA processing.400 Cell Metabolism 17, 399–410, March 5, 2013 ª2013 Elsevier Inc.RESULTS
GRSF1 Is a Mitochondrial Protein
We investigated whether several isoforms of GRSF1 might
be responsible for the multiple roles attributed to the gene.
According to the NCBI database, the GRSF1 gene encodes
two splice variants (i.e., isoform 1 [NM_002092] and isoform 2
[NM_001098477]; Figure 1A). The longer mRNA corresponds
to isoform 1 and encodes a 480 amino acid protein. Isoform 2
contains an alternate exon in the 50 coding region and utilizes
a downstream start codon. Thus, the resulting isoform 2 has
a shorter N terminus that lacks the first 162 amino acids
present in isoform 1. The three conserved qRRM are present in
both GRSF1 variants. Mitochondrial targeting prediction tools
(MitoProt II [Claros and Vincens, 1996]) yield a probability of
98.99% that isoform 1 has a mitochondrial localization signal,
with a cleavage site predicted after tyrosine 118. In contrast, iso-
form 2 is not predicted to have any mitochondrial localization
signal (0.02%, MitoProt; Figure 1A).
We tagged both isoforms of GRSF1 at their carboxyl termini
and expressed them in HeLa cells. GRSF1 isoform 1 was
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Role of GRSF1 in Mitochondrial RNA Granulesobserved in mitochondria, where it colocalized with the mito-
chondrial protein Tom20 (Figure 1B). Intriguingly, this isoform
was concentrated in discrete foci inside the mitochondrial
tubules. In contrast, expression of isoform 2 resulted in a diffuse
staining in both the cytosol and nucleus. The different localiza-
tions between GRSF1 isoforms were confirmed in mitochondrial
import assays where we could successfully import radiolabeled
in vitro-translated GRSF1 isoform 1, but not isoform 2, into mito-
chondria isolated from 143B cells (Figure 1C). This import was
dependent on the membrane potential (DJm), and after import
we observed presequence cleavage of GRSF1 isoform 1, which
was not further investigated.
To analyze the localization of endogenous GRSF1, 143B cells
were immunolabeled with anti-GRSF1 and anti-Tom20 anti-
bodies. GRSF1 was exclusively localized in mitochondria and
accumulated in discrete foci in 143B or HeLa cells, suggesting
that these cells preferentially express isoform 1 (Figure 1B and
Figure 2A). Protein immunoblotting in different cell lysates con-
firmed the expression of isoform 1 in HeLa, 143B, HEK293T,
and Jurkat cells (see Figure S1 online). In addition, in contrast
to other cell types, Jurkat cells showed additional bands of lower
molecular weight, which may correspond to additional isoforms.
In agreement with our import experiment, we observed that
endogenous GRSF1 isoform 1 was protected from degradation
when mitochondria isolated from 143B cells were exposed to
Proteinase K, even when mitochondria were swollen to rupture
their outer membrane (Figure 1D). These data indicate a matrix
localization of the protein, and alkaline sodium carbonate treat-
ment demonstrated that it was not integrated in the inner mito-
chondrial membrane (Figure 1E). Thus, in diverse cell types,
GRSF1 is a mitochondrial matrix protein that is organized in
discrete foci.
GRSF1 Colocalizes with Nascent Mitochondrial RNA in
Mitochondrial RNA Granules
Next we characterized the nature of the foci formed by GRSF1.
To assess whether the foci depend on genetic material of mito-
chondrial origin, we immunolabeled GRSF1 in 143B r0 cells,
which lack mtDNA and therefore mtRNA. Although GRSF1 was
still localized to mitochondria in these cells, the protein was
not concentrated in foci but was rather diffuse in the matrix, indi-
cating that the formation of GRSF1 foci requires the presence of
a mitochondrial genome (Figure S2). The GRSF1 foci were remi-
niscent in terms of both size and distribution of those formed by
mtDNA nucleoids. To test if these foci had overlapping contents,
we immunolabeled HeLa cells with antibodies against both
GRSF1 and the nucleoid marker mitochondrial single-stranded
DNA binding protein (mtSSB). Fewer than 8% of the GRSF1
foci were found to colocalize with mtSSB foci (Figures 2A and
2C). Similar results were obtained with another nucleoid marker,
Twinkle-EGFP (Figure 2C). Since GRSF1 is an RNA-binding
protein, we hypothesized that the GRSF1 foci may contain
RNA and thus performed bromouridine (BrU) labeling experi-
ments to detect nascent mtRNAs, as previously described
(Iborra et al., 2004). Eighty-eight percent of BrU-labeled foci
colocalized with GRSF1 foci, strongly suggesting that GRSF1
associates with nascent RNA in mitochondria (Figures 2B and
2C). We have named these foci composed of nascent RNA
and GRSF1 ‘‘mitochondrial RNA granules’’ (MRGs).CeGRSF1 Is Required to Maintain Mitochondrial Gene
Expression
Given the colocalization of GRSF1 and nascent mtRNA, we
tested whether GRSF1 may play a role in mtRNA metabolism.
Downregulation of GRSF1 was obtained by lipotransfection of
a synthetic RNAi (RNAi1) or by using lentiviral-mediated shRNA
delivery (RNAi2) (Figure 1A and Figure 3A). Interestingly, we
found that the protein levels of COX1 and COX2, two mito-
chondrially encoded proteins, were significantly reduced in
both RNAi1-treated and RNAi2-expressing cells (Figure 3A).
The effect of GRSF1 RNAi on mitochondrially encoded proteins
was specific to the mitochondrial form of GRSF1, since RNAi1
only targets isoform 1 (Figure 1A). GRSF1-depleted cells were
found to adopt a glycolytic metabolism, as shown by acidifica-
tion of the culture medium, a common feature observed when
cells cannot properly perform oxidative phosphorylation (Fig-
ure 3B). To further understand the role of GRSF1 on mitochon-
drial function, we analyzed the levels of mitochondrially encoded
RNAs in GRSF1-depleted 143B cells and found that GRSF1
depletion affected 9 of the 11 mRNA transcription units tested
(Figure 3C). As expected, GRSF1 isoform 1 transcripts them-
selves were reduced by >85% (Figure 3D), whereas nuclear-
encoded transcripts were unaffected or slightly upregulated
(Figure 3E). These results were confirmed by northern analysis
of RNAi2-treated cells and also showed that rRNA and certain
tRNA were affected by the absence of GRSF1 (Figures 3F and
3G and Figure 5). In accordance with these results, we observed
a global decrease in mitochondrial translation products in
RNAi2-infected 143B cells (Figures 3H and 3I). Together these
results show that GRSF1 is required to maintain mitochondrial
gene expression in 143B cells.
RNase P Interacts and Colocalizes with GRSF1 in
Mitochondrial RNA Granules
To gain further insight into themechanismbywhichGRSF1 regu-
lates mtRNA levels, we searched for GRSF1 binding partners.
For this experiment, GRSF1, along with any interacting proteins
was affinity purified from HEK293T cells expressing GRSF1-
FLAG, and the resulting protein mixture was analyzed by mass
spectrometry (Table S1). Among the putative GRSF1 partners,
RNase P showed the highest emPAI value (Ishihama et al.,
2005), with a score of 35.9 and 8.2 for MRPP2 and MRPP1,
respectively. To confirm the interaction between GRSF1 and
MRPP1, we performed reverse coimmunoprecipitation in which
HEK293T cells were transfectedwithMRPP1-FLAG andGRSF1-
HA and immunoprecipitation was performed with anti-FLAG
antibodies. We found that a significant amount of GRSF1-HA
coimmunoprecipitated with MRPP1-FLAG, confirming our initial
findings (Figure 4A). Similar results were obtained when RNA
was degraded with RNase A prior to the pull-down assay, indi-
cating that the interaction between GRSF1 and MRPP1 was
not mediated by RNA. In agreement with these results, we
observed that MRPP1 colocalized with GRSF1 and BrU in
MRGs, with 92% of foci showing both MRPP1 and GRSF1
labeling (Figures 4B and 4C). MRPP3, the third component of
RNase P, was not significantly enriched in the GRSF1 affinity
purification. This was not unexpected, since the affinity between
this subunit and the other two components is known to be weak
and to be significantly decreased in the presence of saltll Metabolism 17, 399–410, March 5, 2013 ª2013 Elsevier Inc. 401
Figure 2. GRSF1 Colocalizes with Nascent Mitochondrial RNA
(A) Confocal analysis of HeLa cells immunolabeled with anti-GRSF1 and anti-mtSSB. Arrowheads, foci formed by GRSF1 in mitochondria. Bottom panels,
magnification.
(B) Confocal analysis of HeLa cells transfected with GRSF1-HA, labeled with BrU, and immunostained with anti-HA and anti-BrU antibodies. Arrowheads, foci
formed by GRSF1 in mitochondria. Bottom panels, magnification.
(C) Quantification of (A) and (B). Data are shown ± SEM (NR 5 cells withR20 foci per cell; in totalR 100 foci were analyzed).
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Role of GRSF1 in Mitochondrial RNA Granules(Holzmann et al., 2008). We therefore checked MRPP3 localiza-
tion by immunocytochemistry using a MYC tag positioned at its
C terminus. We found that, like MRPP1 and GRSF1, MRPP3 also
accumulates inMRGs (Figure 4D). Finally, our results with RNase
P prompted us to investigate whether RNase Z (ELAC2) also co-
localizes with MRGs. However, in contrast to RNase P, ELAC2
was found to be diffuse in the mitochondrial matrix (Figure S3A).
In addition to RNase P, the coimmunoprecipitation experiment
also identified a number of other putative GRSF1 partners,
among which were several RNA-related proteins, including
components of the cytosolic or mitochondrial ribosomes. This
prompted us to test whether GRSF1 itself could be a component
of mitoribosomes. However, using isokinetic sucrose density
gradients we did not find cosedimentation of GRSF1 with either
the mitoribosomal protein MRPL12 or DAP3 (Figure S3B).
Together, these data show that GRSF1 interacts and colocal-
izes with RNase P in mtRNA granules.
Loss of GRSF1 Leads to Aberrant Mitochondrial RNA
Processing
RNase P has previously been reported to play a role in the pro-
cessing of a number of transcripts that are flanked by tRNAs.
RNase P cleaves tRNAs at their 50 end and thereby participates402 Cell Metabolism 17, 399–410, March 5, 2013 ª2013 Elsevier Inc.in the so-called ‘‘tRNA punctuation model’’ (Ojala et al., 1981).
This prompted us to test whether GRSF1 may cooperate with
RNase P in the processing of mitochondrial primary transcripts
involving tRNA excision (a linear representation of the mitochon-
drial genome can be found in Figure 5A). Using northern blot
analyses of mtRNAs from control and GRSF1-depleted 143B
cells, we observed a decrease in mature mitochondrially en-
coded tRNAPhe, 16S rRNA, tRNALeu(UUA/G), MTND1, RNA14,
MTCO3, and MTND5 in GRSF1-deficient cells, confirming the
data obtained by Nanostring analysis as described above
(Figure 3 and Figure 5). In contrast to the decrease in pro-
cessed RNA, we found that several precursors, most notably
tRNAPhe and tRNAVal precursors, were significantly increased
in GRSF1-depleted cells (Figures 5B, 5F, and 5G). Similar results
showing even more dramatic increases were obtained for tRNA-
containing precursors in MRPP1-deficient cells (Figure S4)
(Holzmann et al., 2008). However, in GRSF1-depleted cells, not
all transcripts showed this expression profile, as, for example,
steady-state levels of tRNAMet remained unchanged (Figures
5B, 5F, and 5G).
Except for the 50 upstream region of MTCO1, RNase P is
not involved in the processing of precursor RNA devoid of flank-
ing tRNA (Sanchez et al., 2011). We tested whether instead
Figure 3. GRSF1 Is Required for Mitochon-
drial Gene Expression
(A) Left panel, immunoblot analysis of 143B cells
treated with control (Ctrl) or GRSF1 RNAi1. Right
panel, immunoblot analysis of 143B cells infected
with lentiviruses carrying anempty vector (pLKO)or
a shRNA (RNAi2) against GRSF1. COX1 and COX2
are mitochondrially encoded proteins. SDHB and
Tom20 are nuclear-encoded mitochondrial pro-
teins. Actin is a nuclear-encoded cytosolic protein.
(B) Acidification of the culture medium in GRSF1
RNAi1-treated 143B cells. The number of cells
was the same in both conditions. Similar results
were obtained in GRSF1 RNAi2-infected cells
(data not shown).
(C) NanoString analysis of 11 mitochondrially en-
coded ORFs in control (Ctrl) or GRSF1 RNAi1-
treated 143B cells. RNA14 corresponds to
bicistronic MTATP8-MTATP6 RNA. Data are
shown as mean ± SEM (n = 3).
(D) NanoString analysis of GRSF1 in control (Ctrl)
or GRSF1 RNAi1-treated 143B cells. Data are
shown as mean ± SEM (n = 3).
(E) NanoString analysis of 11 nuclear-encoded
proteins in control (Ctrl) or GRSF1 RNAi1-treated
143B cells. Data are shown as mean ± SEM (n = 3).
(F) Northern blot analysis of 12S and 16S rRNA in
control (Ctrl) or GRSF1 RNAi1-treated cells. TUB,
tubulin.
(G) Phosphorimager quantification of (E). Data are
shown as mean ± SEM (n = 3).
(H) 35S-labeling of mitochondrial translation of
143B cells infected with lentiviruses carrying an
empty vector (pLKO) or a shRNA (RNAi2) against
GRSF1.
(I) Phosphorimager quantification of (H). Data are
normalized to the Ponceau S intensity and are
shown as mean ± SEM (n = 4).
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Role of GRSF1 in Mitochondrial RNA GranulesGRSF1 would play a more general role, including the processing
of the tRNA-less RNA precursors. Analysis of RNA processing at
the RNA14-MTCO3, MTND5-CYB, and MTND6-ncRNA junc-
tions revealed a significant increase in the amounts of precursor
transcripts for RNA14-MTCO3 and MTND5-CYB (Figures 5D,
5F, and 5G). In addition, we found that MTND6, the only mito-
chondrial mRNA encoded by the light strand, was shorterCell Metabolism 17, 399–4in GRSF1-deficient cells (Figure 5D),
whereas certain high-molecular-weight
forms of MTND6 accumulated in the
absence of GRSF1 (Figure 5D, arrows 2,
3, and 4), while others decreased (Fig-
ure 5D, arrow 1). Thus, in contrast to
RNase P, GRSF1 appears to be involved
more generally in the processing of a
wide range of primary transcripts.
Most mtRNA precursors are thought
to have a short life span, although
certain precursors have been reported
to accumulate in mitochondria from
human cells and tissue (Temperley et al.,
2010). Among these, RNA19, a polycis-
tronic RNA composed of 16S rRNA,tRNALeu(UUA/G), and MTND1, is one of the most abundant (Bind-
off et al., 1993). The function of this stable RNA species
is currently unknown, but its accumulation has been described
in several human mitochondrial pathologies (Suzuki et al.,
2011). Northern blot analysis of RNA19 using probes directed
against 16S rRNA, tRNALeu(UUA/G), orMTND1 showed a decrease
in RNA19 in GRSF1 RNAi2-expressing cells (Figures 5C and 5F).10, March 5, 2013 ª2013 Elsevier Inc. 403
Figure 4. GRSF1 Interacts and Colocalizes with RNase P in Mitochondrial RNA Granules
(A) Coimmunoprecipitation of MRPP1-FLAG and GRSF1-HA expressed in HEK293T cells. Pull-down was performed with FLAG antibodies or control IgG (IgG).
OPA1 was used as a negative control.
(B) Confocal analysis of HeLa cells transfected with MRPP1-FLAG, labeled with BrU, and immunolabeled with anti-FLAG and anti-BrU antibodies. Arrowheads,
foci formed by BrU in mitochondria. Bottom panels, magnification.
(C) Confocal analysis of HeLa cells transfected with MRPP1-FLAG, GRSF1-HA, and mitoECFP and immunolabeled with anti-FLAG and anti-HA antibodies.
Arrowheads, foci formed by GRSF1 in mitochondria. Bottom panels, magnification.
(D) Confocal analysis of HeLa cells transfected with MRPP3-MYC, GRSF1-HA, and mitoECFP and immunolabeled with anti-MYC and anti-HA antibodies.
Arrowheads, foci formed by GRSF1 in mitochondria. Bottom panels, magnification.
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Role of GRSF1 in Mitochondrial RNA GranulesOur data indicate that mtRNA processing is strongly perturbed
in the absence of GRSF1, in a manner that appears to extend
beyond dysfunction of RNase P.
Short-Term Transcription Inhibition Results in the Loss
of Mitochondrial RNA Granules
Asmentioned above, MRGs are not observed in r0 cells that lack
mtRNA (Figure S2).We hypothesized that RNAplays an essential
role in the formation of MRGs. To test this hypothesis, we in-
hibited RNA transcription in 143B cells by treatment with 3 mM404 Cell Metabolism 17, 399–410, March 5, 2013 ª2013 Elsevier Inc.actinomycin D (Act D) for 2 hr (Figure 6A). Importantly, whereas
transcription inhibition did not affect the level of mature tRNAPhe,
tRNAVal, or MTCO3 transcripts, it significantly affected their
precursor RNAs (Figures 6B and 6C). We then tested whether
transcription inhibition could have an impact on the formation of
MRGs. HeLa cells transfected with GRSF1-HA were incubated
for 2 hr with 3 mM ActD or 3 mg/mL ethidium bromide (EtBr),
another transcription inhibitor, and were subsequently immuno-
stained with anti-HA and anti-Tom20 antibodies. Whereas
untreated cells showed MRGs, those treated with ActD or EtBr
Figure 5. Loss of GRSF1 Leads to Aberrant
Mitochondrial RNA Processing
(A) Linear representation of the mitochondrial
genome. Red, rRNA; green, ORF; blue, tRNA.
RNA19 corresponds to the polycistronic 16S
rRNA  tRNALeu(UUA/G)  MTND1 RNA. RNA14
corresponds to bicistronic MTATP8-MTATP6
RNA. HSP, heavy-strand promoter. LSP, light-
strand promoter.
(B) Northern blot analysis of tRNA-containing
junctions from 143B cells treated with lentiviruses
carrying an empty vector (pLKO) or GRSF1 RNAi2
using probes directed against mitochondrial
tRNAPhe, tRNAVal, and tRNAMet. Arrows indicate
RNA precursors. Short and long correspond to
different exposures.
(C) Northern blot analysis of RNA19 (16S rRNA 
tRNALeu(UUA/G)  MTND1) in 143B cells treated
with lentiviruses carrying an empty vector (pLKO)
or GRSF1 RNAi2 using probes directed against
16S rRNA, tRNALeu(UUA/G), or MTND1. Arrows
indicate RNA19. Short and long correspond to
different exposure time.
(D) Northern blot analysis of tRNA-less RNA junc-
tions in 143B cells treated with lentiviruses
carrying an empty vector (pLKO) or GRSF1 RNAi2
using probes directed against RNA14 (MTATP8 
MTATP6), MTCO3, MTND5, and MTND6. Arrows
and numbers indicate RNA precursors. Short and
long correspond to different exposure times.
(E) Northern blot analysis of control from 143B
cells treated with lentiviruses carrying an empty
vector (pLKO) or GRSF1 RNAi2 using probes
directed against tubulin. Note that two isoforms of
tubulin are recognized by the probe. Short and
long correspond to different exposure time.
(F) Phosphorimager quantification of (B)–(D).
MTND6 was not quantified due to its diffused
pattern. Data are normalized to tubulin and are
shown as mean ± SEM (nR 3).
(G) Ratio between precursor and mature RNA,
when applicable. MTND6 was not quantified due
to its diffused pattern. Data are shown as mean ±
SEM (nR 3).
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Role of GRSF1 in Mitochondrial RNA Granuleslacked MRGs as assessed by GRSF1 immunostaining. Indeed,
in cells treated with transcription inhibitors, GRSF1 was homo-
genously distributed in the mitochondrial matrix (Figure 6D).
Similar results were obtained using MRPP1-FLAG as a MRG
marker (data not shown). All together, these experiments show
a correlation between a reduction in the level of precursorCell Metabolism 17, 399–4RNAs and the disappearance of MRGs,
suggesting that unprocessed transcripts
may be required for the organization
of MRGs.
The Kinetics of RNA Release from
MRGs Is Dependent on RNA
Processing
All data presented above suggest that
MRGs may be sites where precursor
RNA transcripts converge to be pro-
cessed before release (Figure 6A). Basedon this hypothesis, we predicted that altering RNA processing
should increase the time RNA precursors would spend within
the granules. To test this hypothesis, we measured the half-life
of BrU-labeled MRGs following a BrU/uridine pulse chase. To
perform this experiment, cells were labeled during a 60min pulse
of BrU followed by a chase with excess uridine for up to 180 min.10, March 5, 2013 ª2013 Elsevier Inc. 405
Figure 6. Transcription Inhibition Induces
the Disappearance of Mitochondria RNA
Granules
(A) Working model: we hypothesize that nascent
mitochondrially encoded precursor RNAs con-
verge to mitochondrial RNA granules (MRGs).
MRGs contain nascent RNAs, GRSF1, and RNase
P. Inhibition of mitochondrial transcription with
actinomycin D (ActD) or ethidium bromide (EtBr),
as well as inhibition of RNA processing with RNAi
againstGRSF1orMRPP1, is predicted to affect the
formation of MRGs. mtDNA, mitochondrial DNA.
(B) Northern blot analysis of 143B cells treated for
0, 60, or 120 min with 3 mM of ActD using probes
directed against tRNAPhe, tRNAVal, MTCO3, and
tubulin. Arrowheads, precursor RNA. Note that
two isoforms of tubulin are recognized by the
probe. Short and long correspond to different
exposure times.
(C) RNA precursor/mature ratio after phosphor-
imager quantification of (B). Data are shown as
mean ± SEM (n = 3).
(D) Confocal analysis of HeLa cells transfected
with GRSF1-HA and treated for 120 min with 3 mM
of ActD, 3 mg/ml EtBr. Immunolabeling was per-
formed using anti-HA and anti-Tom20 antibodies.
Arrowhead, MRG.
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Role of GRSF1 in Mitochondrial RNA GranulesAsexpected, before thechase,BrU-labeled transcriptswerecon-
centrated in MRGs (Figure 7A). Following addition of unlabeled
uridine, thenumberof cellswithmitochondrial BrU foci decreased
with time up to 90 min, at which point no cell with labeled MRGs
could be detected (Figures 7A and 7C). In agreement with pre-
vious results from Iborra and collaborators (Iborra et al., 2004),
weestimated that thehalf-life ofBrU fociwas50min (Figure7C).
We next perturbed RNA processing by depleting cells of either
GRSF1 or MRPP1, and then the half-life of BrU positive MRGs406 Cell Metabolism 17, 399–410, March 5, 2013 ª2013 Elsevier Inc.was measured. 143B cells were infected
with lentiviruses carrying an empty vector
or a shRNA against GRSF1, which led
to a drastic reduction in GRSF1 expres-
sion in all cells (Figure 7B). BrU pulse-
labeling experiments showed that the
half-life of BrU-labeled MRGs was signifi-
cantly longer in GRSF1-depleted cells
(130 min) than in control cells (50 min)
(Figures 7A and 7C). Similar results were
obtained when GRSF1-depleted cells
and control cells were mixed and cultured
together for 24hr,prior toBrUpulse-chase
and microscopic analysis. Expression
of GFP in the control cells allowed us
to distinguish each population. Before
chase, both control and GRSF1-deficient
cells expressed BrU-labeled MRGs
whose number and fluorescence intensity
did not appear to differ between the
two populations (Figure 7D). In contrast,
after 90 min of chase, only the GRSF1-
depleted cells showed labeled MRGs. A
similar observation was made when RNA
processing was altered by downregulation of MRPP1, where
again we observed a strong delay in the disappearance of BrU-
labeled MRGs (Figure S5A). This effect was unlikely to be the
consequence of a defect in mitochondrial translation, since
inhibition of translation using the protein synthesis inhibitor chlor-
amphenicol did not modify the half-life of BrU-labeled MRGs
(FigureS5B). All together, our data demonstrate that thepresence
of nascent RNA in MRGs is transient and that its release from
MRGs depends on the efficiency of RNA processing.
Figure 7. The Kinetics of RNA Release from
MRGs Is Dependent on GRSF1
(A) Confocal analysis of 143B infected with pLKO
or GRSF1 RNAi2-carrying lentiviruses after 60 min
of BrU pulse and 0 or 90 min of chase with uridine.
The parameters used for the entire analysis were
identical for both conditions. Note that the
thresholds were set up so that only the BrU foci
could be visualized.
(B) Confocal analysis of endogenous GRSF1 and
Tom20 in pLKO or GRSF1 RNAi2-infected cells.
The parameters used for the entire analysis were
identical for both conditions.
(C) Number of cells with BrU foci after 60 min of
BrU pulse and up to 180 min of chase with uridine
in 143B cells infected with pLKO or GRSF1 RNAi2-
carrying lentiviruses. Cells were counted using
widefield microscopy. Data are shown as mean ±
SEM (n = 3).
(D) Confocal analysis of BrU pulse chase of mixed
control (green) and GRSF1 RNAi2 cells. Control
143B cells were infected with lentiviruses carrying
an empty pLKO vector and lentiviruses carrying
the GFP gene (pLKO + GFP), whereas GRSF1-
depleted cells were infected with lentiviruses ex-
pressing GRSF1 RNAi2. All control cells were
found to express GFP (data not shown). The two
cell populations were mixed, selected with puro-
mycin for 24 hr to eliminate those cells that would
not have been infected by lentiviruses, and incu-
bated with BrU for 60 min before chase with
uridine. Cells were immunostained with anti-BrU
and anti-Tom20 antibodies.
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Here, we report that isoform 1 of the RNA-binding protein GRSF1
colocalizeswith nascent RNAandRNaseP in a submitochondrial
compartment that we have called ‘‘mitochondrial RNA granules’’
(MRGs). We found that GRSF1 is required for mtRNA expressionCell Metabolism 17, 399–4and protein synthesis in mitochondria.
Moreover, downregulation of GRSF1 or
MRPP1, a subunit of RNase P, delays
the transit of nascent RNA through
MRGs, leading to reduced levels of
mature mtRNA and reduced mito-
chondrial protein synthesis. These data
strongly suggest that mtRNA pro-
cessing and generation of functional
RNA species are dependent on the integ-
rity of the MRG.
Little is known about the mechanisms
and regulation of mtRNA processing.
We have identified GRSF1 as a key player
in the processing of tRNA-containing
and tRNA-lacking precursors. We have
shown that GRSF1 binds the MRPP1
and MRPP2 subunits of RNase P, while
the third subunit, MRPP3, was shown to
colocalize with GRSF1 by immunohisto-
chemistry. In addition, GRSF1 probablyalso acts in an RNase P-independent manner, since its activity
is implicated in the processing of the tRNA-lacking precursors.
Indeed, we found that GRSF1 is the first protein to be required
for the processing of RNA14-MTCO3 and MTND6-ncRNA pre-
cursors. Themechanism by which GRSF1 exerts these functions
is still unclear, and it remains to be determined whether the10, March 5, 2013 ª2013 Elsevier Inc. 407
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Role of GRSF1 in Mitochondrial RNA Granulesprotein is able to bind to specific nucleotide sequences present
in these precursors.
Is GRSF1 also involved directly in mitochondrial protein
synthesis, in addition to its role in RNA processing? We cannot
rule this out, and the marked decrease in de novo mitochondrial
protein synthesis upon GRSF1 depletion is perhaps more
dramatic than would be predicted solely from the effects on
RNA processing or stability. Moreover, we did see mitoriboso-
mal proteins in the crude immunoprecipitation experiment. How-
ever, our sucrose gradient density fractionation showed no
evidence of tight association between GRSF1 and mitoriboso-
mal subunits. Further investigations will be required to under-
stand whether GRSF1 could play a direct role in translation,
whether a minor fraction of GRSF1 also interacts with themature
ribosomes, or whether the presence of mitoribosomal proteins in
the immunoprecipitation corresponds to intermediates in the
process of mitoribosome assembly.
We show that the MRGs are distinct from mitochondrial
nucleoids. Only fewer than 10% of them overlapped with the
DNA-containing structures, and these MRGs may correspond
to BrU-labeled foci found in close proximity to nucleoids as
described by Iborra et al. (2004). Nucleoids overlapping with
newly synthesized RNA have been previously reported to
contain the mitochondrial transcription factor TEFM and have
therefore been described as transcriptionally active nucleoids
(Minczuk et al., 2011). Taken together, these results suggest
that the precursor transcripts may rapidly accumulate and
may themselves promote the formation of MRGs by recruiting
GRSF1, RNase P, and possibly other proteins involved in RNA
precursor processing. This is supported by our findings that tran-
sient inhibition of transcription specifically affects the levels of
precursor but not mature RNA and leads to the concomitant
disappearance of MRGs. In contrast, inhibition of translation
has no impact on the formation of MRGs, excluding the possi-
bility that the disappearance of MRGs in cells exposed to tran-
scription inhibitors is due to a drop in mitochondrial encoded
proteins. How newly synthesized RNA dynamically induces the
formation of granules is unknown, although this is likely to be
through interaction with proteins, and thus a more complete
analysis of the protein components of the MRG is likely to prove
informative. In this context, it was recently proposed that RNA
binding proteins containing low-complexity sequences could
represent the organizing principle for the formation of cytosolic
RNA granules (Han et al., 2012; Kato et al., 2012). Whether
proteins of this type are involved in the formation of MRGs
remains to be determined.
It is likely that MRGs are dynamic structures whose number
and composition may vary according to the metabolic state
of the cell. Based on the phenotypic consequences of GRSF1
and RNase P knockdown on RNA processing, we postulate
that at least part of RNA processing occurs in MRGs. This
does not exclude the possibility that GRSF1 and RNase P may
have additional functions outside MRGs, nor does it exclude
the possibility that MRGs may have other functions beyond
a role in RNA processing. Based on our hypothesis on the role
of MRGs in processing of tRNA-containing polycistronic tran-
scripts, we expected that RNase Z, the enzyme that cleaves
tRNA at its 30 terminus, would be enriched in MRGs; however,
this does not appear to be the case. Instead, RNase Z immuno-408 Cell Metabolism 17, 399–410, March 5, 2013 ª2013 Elsevier Inc.staining is diffuse in the mitochondrial matrix, suggesting that
the protein may have additional functions outside of MRGs
and/or that its mitochondrial concentration is high enough in
the matrix and not limiting for RNA processing in MRGs. Alterna-
tively, RNase Z-induced cleavage of tRNA in precursor tran-
scripts could occur outside of MRGs. Indeed, previous work
has demonstrated that tRNAs are cleaved sequentially, initially
at the 50 end by RNase P, then at the 30 end by RNase Z. Indeed,
cells treated with RNAi against RNase P accumulate 30 tRNA
junctions (Sanchez et al., 2011). The MRG transcriptome anal-
ysis currently in progress in our laboratory should allow us to
determine which precursor RNAs are found in these structures
and may shed more light on the MRG-dependent events in-
volved in mtRNA processing.
In previous experiments, Iborra et al. (2004) observed the
formation of BrU-positive foci that decreased exponentially after
chase. In agreement with their results, we calculated that the
half-life of BrU-labeled RNA in MRGs is 50 min. The decrease
in BrU-positive foci could be explained by RNA degradation or
by its release into the matrix. Although we do not exclude the
possibility of RNA degradation in MRGs, we favor the hypothesis
that the granules are no longer visible when the transcripts have
been released into the matrix, where their concentration drops
significantly. Based on this hypothesis, we predicted that a
dysfunction of the RNA processing machinery should lead to
an increase in the time spent by nascent RNAs in MRGs. This
prediction was confirmed by our observation that in the absence
of GRSF1 or MRPP1, the persistence of BrU-positive MRGs was
significantly increased compared to control.
In conclusion, we have identified a new mitochondrial sub-
compartment, the mitochondrial RNA granules, where GRSF1
and RNase P act together to ensure mtRNA processing.
Further characterization of the proteome and transcriptome of
these structures should prove to be very useful in advancing
our understanding of mtRNA processing and may reveal other
essential posttranscriptional steps involved in mitochondrial
gene regulation.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, RNA Interference, and Chemicals
All cell culture reagents and chemicals were purchased from Sigma unless
stated otherwise. Cells were cultured in Dulbecco’s modified Eagle medium
(DMEM) supplemented with 10% heat-inactivated fetal bovine serum,
100 u/ml penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine in 5%
CO2 at 37
C. 143B r0 cells were grown in the same medium supplemented
with 110 mg/ml sodium pyruvate and 50 mg/ml uridine. Transfection of cells
was done using Fugene (Roche). Mitochondrially targeted ECFP (mitoECFP)
was from Clontech. Twinkle-EGFP was a gift from J.N. Spelbrink. MRPP1-
FLAG and MRPP3-myc were gifts fromW. Rossmanith. For RNA interference,
143B cells were transfected with interferin (Polyplus) or lipofectamine
RNAiMax (Invitrogen) according to the the manufacturer’s instructions, and
cells were analyzed 2–4 days posttransfection. pLKO.1 containing GRSF1
RNAi2 lentiviral vector was obtained from Sigma, and lentiviruses were
produced according to the manufacturer’s instructions. After viral infection,
cells were always selected for 24 hr with 3 mg/ml puromycin and left to recover
for >24 hr before analysis. The same RNAi2 sequence was cloned into pLKO-
TetON, a tetracycline-inducible version of pLKO (Addgene). Induction was
achieved with 1 mg/ml tetracycline for 2–4 days. Inducible and noninducible
versions of RNAi2 showed the same effect on RNA processing and were
used indifferently to express RNAi2 (data not shown). RNAi sequences are
described in Table S2.
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BrU pulse was performed using 5 mM 5-BrU (Sigma) for 60 min. For chase,
cells were washed twice with culture medium and incubated in 25 mM uridine
for the indicated times. Fixation wasmade in 4%paraformaldehyde for 10min.
Immunofluorescence was performed in PBS containing 3% BSA, 0.1% Triton
X-100, and 20 u/ml RNasin (Promega). Microscopy was performed with ZEISS
AXIOZ1 or ZEISS LSM700 confocal microscopes. To quantify the foci-foci
colocalization, cells were labeled with antibodies against the protein/RNA of
interest and GRSF1 and imaged, and >20 foci in >5 cells (>100 foci in total)
per condition were blindly labeled on the protein/RNA pictures using ImageJ.
Pictures were then merged, and the frequency of colocalization with GRSF1
foci was determined.
Antibodies
Antibodies used were as followed: BrU/BrdU (Roche 11170376001), Tom20
(Santa Cruz FL-145), PHB (Neomarkers AB-1), OPA1 (BD PharMingen
612606), COX1 (Invitrogen 459600), COX2 (Invitrogen 35-8200), SDHB (Abcam
AB14714), DAP3 (Abcam 13893), Actin (Sigma AC-40), and ELAC2 (Protein-
tech 10071-1-AP). GRSF1 antibodies were a gift from J. Wilusz, mtSSB from
M. Zeviani, and HSP90 b from D. Picard. Cytochrome c antibodies were
made in our laboratory. FITC, Texas red, or AMCA-coupled secondary anti-
bodies were from Vector.
RNA Extraction and Northern Blotting
Total RNAwas extracted with TRI reagent (Sigma). RNA (15 mg) was separated
on denaturing formaldehyde agarose gels and transferred to nylon mem-
branes. Membranes were hybridized with 32P labeled in vitro-transcribed T7
RNA probes in 50% formamide, 7% SDS, 0.2 M NaCl, 80 mM sodium phos-
phate (pH 7.4), and 100 mg/ml salmon sperm DNA. Hybridization was carried
out at 60C for 3 hr. Membranes were subsequently rinsed in 13 SSC, 0.1%
SDS and washed for 30 min in 0.5% SSC, 0.1% SDS. Imaging and quantifica-
tion were performed with a phosphorimager (Bio-Rad). Probes are described
in Table S2.
NanoString
The NanoString analysis was performed by the genomics platform of the
University of Geneva. HDAC, NUP155, and tubulin were used to normalize
the data. Probes are described in Table S2.
Mitochondria-Rich Fraction Isolation, Proteinase K Accessibility
Test, and Alkali Treatment
Cell fractionation was done in MB buffer (210 mM mannitol, 70 mM sucrose,
10 mM HEPES-KOH [pH 7.4], 1 mM EDTA) using a glass homogenizer
(Kontes). Nuclei and unbroken cells were discarded after centrifugation for
5min at 2,000 g. Themitochondria-rich fraction corresponded to the pellet ob-
tained after a 10 min centrifugation at 13,000 g. For the PK accessibility test,
mitochondria were resuspended at a final concentration of 0.5 mg/ml in MB,
swelling buffer (10 mM HEPES-KOH [pH 7.4]), or MB + 0.2% (v/v) Triton
X-100. PK was added to a final concentration of 50 mg/ml, and the mixture
was incubated on ice for 20 min. PMSF (2 mM) was then added to inhibit the
PK. After TCA precipitation, samples were analyzed by western blotting.
For alkaline sodium carbonate extraction, 100 mg of mitochondria was re-
suspended in 100 mM Na2CO3 (pH 11.5) and incubated on ice for 30 min
before a 30 min centrifugation at 100,000 g.
Pulse Labeling of Mitochondrial Translation
143B cells were incubated for 20 min in methionine/cysteine-free DMEM
(Sigma) complemented with dialysed serum and 2 mM L-glutamine. Cells
were then incubated for 1 hr in the same medium in the presence of
100 mg/ml emetine and 100 mCi/ mL 35S-labeled methionine/cysteine
(PerkinElmer). Total protein concentration of cell lysates was measured by
Bradford (Bio-Rad), and lysates were resolved on a 15%–20% tricine gel,
transferred to a nitrocellulose membrane, and analyzed by autoradiography.
Import of Recombinant Radiolabeled GRSF1 into Isolated
Mitochondria
In vitro synthesis of radiolabeled GRSF1 isoforms was performed with TNT kit
(Promega). Import into isolated mitochondria was performed according toCeKoppen et al. (2009). PK was used instead of trypsin to degrade nonimported
material.
Affinity Purification of GRSF1-Interacting Proteins and
Coimmunoprecipitation
Affinity purification and identification of GRSF1-interacting proteins were per-
formed on mitoplasts from GRSF1-FLAG-expressing HEK293T cells as previ-
ously described (Richter et al., 2010). To confirm the interaction between
MRPP1 and GRSF1, HEK293T cells were transfected with MRPP1-FLAG
and GRSF1-HA. Two days after transfection, mitochondria were isolated
and lysed in lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 10 mM
MgCl2, 1 mM EDTA, 1% [v/v] Triton X-100, and protease inhibitor cocktail
[Roche]). Coimmunoprecipitation of MRPP1-FLAG with GRSF1-HA was per-
formed on mitochondria from HEK293T cells expressing both constructs.
Mitochondria were homogenized in lysis buffer, and pull-down was performed
using polyclonal anti-FLAG antibodies (Sigma). After washing and elution in
SDS-containing loading buffer, proteins were separated by SDS-PAGE.
RNase A treatment was performed by adding 100 mg/ml RNase A (Fermentas)
during lysis.
Isokinetic Sucrose Gradient
143B cells were lysed in lysis buffer and layered on a 2 ml 10%–30% (w/v)
sucrose gradient as previously described (Richter et al., 2010). Samples
were centrifuged for 3 hr at 100,000 g; 100 ml fractions were collected and
separated by SDS-PAGE.
Statistical Analysis
Data are represented as mean ± SEM and are representative of more than
three independent experiments. Stars correspond to a two-tailed Student
t test, with *p < 0.05, **p < 0.01, and ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and two tables and can be
found with this article at http://dx.doi.org/10.1016/j.cmet.2013.02.005.
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